In a Phase I trial, what must be verified first before administering the investigational agent?

In a Phase I trial, what must be verified first before administering the investigational agent?

• A. Calculate Body Surface Area (BSA)
• B. Ensure that appropriate blood product transfusion consent was obtained
• C. Verify necessary blood work has been obtained
• D. Verify informed consent has been obtained

Answer: (D)

Before giving any investigational drug in a Phase I trial, informed consent must be obtained and documented. This ensures the patient fully understands the study, including risks, potential benefits, alternatives, and the right to withdraw, and confirms that participation is voluntary. Without valid informed consent, no trial procedures or dosing should proceed, regardless of other preparatory steps. While baseline labs, eligibility criteria, or protocol-specific consents (like transfusion) may be required, they do not replace the fundamental need for informed consent.

Before giving any investigational drug in a Phase I trial, informed consent must be obtained and documented. This ensures the patient fully understands the study, including risks, potential benefits, alternatives, and the right to withdraw, and confirms that participation is voluntary. Without valid informed consent, no trial procedures or dosing should proceed, regardless of other preparatory steps. While baseline labs, eligibility criteria, or protocol-specific consents (like transfusion) may be required, they do not replace the fundamental need for informed consent.